23.2 - At the request of the Medical Monitor, written reports will be generated biannually to correlate with DSMB reports. 20151015 0730 RB Title Page - As a result of the conversion to the electronic myIRB system, t he new IRB number was added . 2.1 10.1 15.3.2 - To minimize variability, Group B subjects with an ANC < 1000/µL and/or platelet count < 100,000/µL at time of non -myeloablative work -up will receive vaccine therapy but will not receive non- myeloablative conditioning . Re-MATC H Protocol Page 7 of 106 Version: 20180628 Summary of Protocol Changes Version Date Sections Revised Purpose 2.1 8 15.1 15.2.1 15.3.2 - The l anguage regarding DCs and/or xALT release criteria or targeted dose was amended for clarity . 2.1 8 15.3.2 - The infusion of PBSCs 72 hours following fludarabine, if successfully collected, was added for Group B patients to potentially enhance the immune response. 2,2 - The schema was updated to state that the pheresis collection is sent to UF.